Perjeta 420 MG/14 ML vial 14ML
Ended Awarded
- Contract number
- SPE2DB25FX1XN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,557
Award facts
- Contract value 100% obligated
- $4,557.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $4,557.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 mL vials. This delivery order, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, represents a tactical pharmaceutical procurement supporting military healthcare operations. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open federal marketplace.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million through November 2026. The contract vehicle enables the agency to procure an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. Perjeta, a monoclonal antibody used in oncology treatment protocols, exemplifies the specialized pharmaceutical products delivered through this contract to support military medical supply requirements across the federal healthcare system.
Quick answers
Who was awarded contract SPE2DB25FX1XN?
SPE2DB25FX1XN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 6, 2025.
How much is contract SPE2DB25FX1XN worth?
The government has obligated $4,557 on SPE2DB25FX1XN.
Is contract SPE2DB25FX1XN an order under another contract?
Yes. SPE2DB25FX1XN is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX1XN competed?
The extent of competition for SPE2DB25FX1XN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award